Search in:

Open Access Rheumatology: Research and Reviews Volume 3, 2011 - Issue

Submit an article Journal homepage

Open access

140

Views

CrossRef citations to date

Altmetric

Review

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis

Masahiko Mihara1 Product Research Department, Chugai Pharmaceutical Co Ltd, Fuji-Gotemba Research Laboratories, Shizuoka, JapanCorrespondence[email protected]

Yoshiyuki Ohsugi2 Chugai Pharmaceutical Co Ltd, Tokyo, Japan

Tadamitsu Kishimoto3 Laboratory of Immunoregulation, Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan

Pages 19-29 | Published online: 28 Feb 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (22)

Joy H. Peterson, Neha S. Paranjape, Nina Grundlingh & Jennifer L. Priestley. (2022) Outcomes and Adverse Effects of Baricitinib Versus Tocilizumab in the Management of Severe COVID-19*. Critical Care Medicine 51:3, pages 337-346.
Crossref

Venkatesh Pilla Reddy, Eman El‐Khateeb, Heeseung Jo, Natalie Giovino, Emily Lythgoe, Shringi Sharma, Weifeng Tang, Masoud Jamei & Amin Rastomi‐Hodjegan. (2021) Pharmacokinetics under the COVID‐19 storm. British Journal of Clinical Pharmacology 89:1, pages 158-186.
Crossref

SHAILA JAY SHAH, JAY H. SHAH & RAVI PATEL. (2022) ROLE OF TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE COVID-19 PNEUMONIA. Asian Journal of Pharmaceutical and Clinical Research, pages 121-125.
Crossref

Zhuoyu Zhang, Lunan Liu, Chao Ma & Weiqiang Chen. (2022) A Computational Model of Cytokine Release Syndrome during CAR T‐Cell Therapy. Advanced Therapeutics 5:10, pages 2200130.
Crossref

Reinhart Speeckaert, Arno Belpaire, Marijn Speeckaert & Nanja van Geel. (2022) The delicate relation between melanocytes and skin immunity: A game of hide and seek. Pigment Cell & Melanoma Research 35:4, pages 392-407.
Crossref

Bingying Dai, Liqing Ding, Lijuan Zhao, Honglin Zhu & Hui Luo. (2022) Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights. Frontiers in Pharmacology 13.
Crossref

Saranya B Gomathy, Ayush Agarwal & Venugopalan Y Vishnu. (2022) Molecular Therapy in Myasthenia Gravis. Neurology 18:1, pages 49.
Crossref

Zhaohong Tan, Michelle Meng Huang Mok, Win Mar Soe, Thomas Paulraj Thamboo, Jessamine Geraldine Goh, Qi Hui Sam, Motomi Osato, Sharada Ravikumar & Louis Yi Ann Chai. (2021) Tocilizumab Induces IL-10-Mediated Immune Tolerance in Invasive Candidiasis. Journal of Fungi 7:8, pages 656.
Crossref

Anastasia V. Poznyak, Dwaipayan Bharadwaj, Gauri Prasad, Andrey V. Grechko, Margarita A. Sazonova & Alexander N. Orekhov. (2021) Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines. International Journal of Molecular Sciences 22:13, pages 7061.
Crossref

Santhamani Ramasamy & Selvakumar Subbian. (2021) Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. Clinical Microbiology Reviews 34:3.
Crossref

Arjun Sharma, Konstantinos Kontodimas & Markus Bosmann. (2021) Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19. Frontiers in Medicine 8.
Crossref

Dalia Barayan, Abdikarim Abdullahi, Roohi Vinaik, Carly M. Knuth, Christopher Auger & Marc G. Jeschke. (2021) Interleukin‐6 blockade, a potential adjunct therapy for post‐burn hypermetabolism. The FASEB Journal 35:5.
Crossref

Stefano Squarzoni, Elisa Schena, Patrizia Sabatelli, Elisabetta Mattioli, Cristina Capanni, Vittoria Cenni, Maria Rosaria D'Apice, Davide Andrenacci, Giuseppe Sarli, Valeria Pellegrino, Anna Festa, Fabio Baruffaldi, Gianluca Storci, Massimiliano Bonafè, Catia Barboni, Mara Sanapo, Anna Zaghini & Giovanna Lattanzi. (2021) Interleukin‐6 neutralization ameliorates symptoms in prematurely aged mice. Aging Cell 20:1.
Crossref

Haneen Yahia, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy & Mohamed F. El-Yamany. (2020) IL-6/STAT3 and adipokine modulation using tocilizumab in rats with fructose-induced metabolic syndrome. Naunyn-Schmiedeberg's Archives of Pharmacology 393:12, pages 2279-2292.
Crossref

Julie C. Worrell & Steven O'Reilly. (2020) Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis. Journal of Autoimmunity 113, pages 102526.
Crossref

Roberto Gomeni, Tianhong Xu, Xuejuan Gao & Françoise Bressolle-Gomeni. (2020) Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2. Journal of Pharmacokinetics and Pharmacodynamics 47:3, pages 189-198.
Crossref

Yen-Ju Lin, Martina Anzaghe & Stefan Schülke. (2020) Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells 9:4, pages 880.
Crossref

Atul Deodhar, Dafna D. Gladman, Iain B. McInnes, Sebastian Spindeldreher, Ruvie Martin, Luminita Pricop, Brian Porter, Jorge SafiJr.Jr., Abhijit Shete & Gerard Bruin. (2020) Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis. The Journal of Rheumatology 47:4, pages 539-547.
Crossref

Ali Maleki, Fatemeh Sayyadipour, Hamid Ahmadi, Masoud Soleimani & Fakhredin Saba. (2020) The Statue of Cytokines Therapy in Blood Transfusion Running Cytokine and Blood Transfusion. Cell and Tissue Biology 13:6, pages 407-417.
Crossref

Rosa P. Gomariz, Yasmina Juarranz, Mar Carrión, Selene Pérez-García, Raúl Villanueva-Romero, Isidoro González-Álvaro, Irene Gutiérrez-Cañas, Amalia Lamana & Carmen Martínez. (2019) An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance. Frontiers in Endocrinology 10.
Crossref

K. Kuet & M. Goodfield. (2014) Multiple halo naevi associated with tocilizumab. Clinical and Experimental Dermatology 39:6, pages 717-719.
Crossref

Sohita Dhillon. (2013) Intravenous Tocilizumab: A Review of Its Use in Adults with Rheumatoid Arthritis. BioDrugs 28:1, pages 75-106.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis

Articles from other publishers (22)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis

Citations (22)

Articles from other publishers (22)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date